The phenotypic spectrum of COL2A1 mutations†
Gen Nishimura
Department of Radiology, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
Search for more papers by this authorNobuhiko Haga
Department of Orthopedics, Shizuoka Children's Hospital, Shizuoka, Japan
Search for more papers by this authorHiroshi Kitoh
Department of Orthopedics, Nagoya University School of Medicine, Nagoya, Japan
Search for more papers by this authorYoko Tanaka
Department of Pediatrics, Tokyo Dental College Ichikawa Hospital, Tokyo, Japan
Search for more papers by this authorToru Sonoda
Department of Pediatrics, Miyazaki Medical College, Miyazaki, Japan
Search for more papers by this authorMiho Kitamura
Department of Orthopedic Surgery, Clark Hospital, Hokkaido, Japan
Search for more papers by this authorShuya Shirahama
Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo, Japan
Search for more papers by this authorTaichi Itoh
Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo, Japan
Search for more papers by this authorEiji Nakashima
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, Tokyo, Japan
Search for more papers by this authorHirofumi Ohashi
Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorCorresponding Author
Shiro Ikegawa
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, Tokyo, Japan
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, JapanSearch for more papers by this authorGen Nishimura
Department of Radiology, Tokyo Metropolitan Kiyose Children's Hospital, Tokyo, Japan
Search for more papers by this authorNobuhiko Haga
Department of Orthopedics, Shizuoka Children's Hospital, Shizuoka, Japan
Search for more papers by this authorHiroshi Kitoh
Department of Orthopedics, Nagoya University School of Medicine, Nagoya, Japan
Search for more papers by this authorYoko Tanaka
Department of Pediatrics, Tokyo Dental College Ichikawa Hospital, Tokyo, Japan
Search for more papers by this authorToru Sonoda
Department of Pediatrics, Miyazaki Medical College, Miyazaki, Japan
Search for more papers by this authorMiho Kitamura
Department of Orthopedic Surgery, Clark Hospital, Hokkaido, Japan
Search for more papers by this authorShuya Shirahama
Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo, Japan
Search for more papers by this authorTaichi Itoh
Center for Molecular Biology and Cytogenetics, SRL Inc., Tokyo, Japan
Search for more papers by this authorEiji Nakashima
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, Tokyo, Japan
Search for more papers by this authorHirofumi Ohashi
Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan
Search for more papers by this authorCorresponding Author
Shiro Ikegawa
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, Tokyo, Japan
Laboratory for Bone and Joint Diseases, SNP Research Center, RIKEN, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, JapanSearch for more papers by this authorCommunicated by David L. Rimoin
Abstract
Heterozygous mutations of COL2A1 create several clinical entities collectively termed type II collagenopathies. These disorders not only impair skeletal growth but also cause ocular and otolaryngological abnormalities. The classical phenotypes include the spondyloepiphyseal dysplasia (SED) spectrum with variable severity, Stickler dysplasia type I (STD-I), and Kniest dysplasia (KND). Most COL2A1 mutations occur in the triple helical region of alpha 1(II) chains: the SED spectrum is mostly attributed to missense mutations that substitute bulky amino acids for glycine residues, STD-I to haploinsufficiency of truncation mutations, and KND to exon skipping due to splice-site mutations. To further elucidate the genotype-phenotype relationship of type II collagenopathies, we examined COL2A1 mutations in 56 families that were suspected of having type II collagenopathies, and found 38 mutations in 41 families. Phenotypes for all 22 missense mutations and one in-frame deletion in the triple helical region fell along the SED spectrum. Glycine to serine substitutions resulted in alternating zones that produce severer and milder skeletal phenotypes. Glycine to nonserine residue substitutions exclusively created more severe phenotypes. The gradient of the SED spectrum did not necessarily correlate with the occurrence of extraskeletal manifestations. All nine truncation or splice-site mutations in the triple helical or N-propeptide region caused STD-I or KND, and extraskeletal changes were inevitable in both phenotypes. All six C-propeptide mutations produced a range of atypical skeletal phenotypes and created ocular, but not otolaryngological, changes. Hum Mutat 26(1), 36–43, 2005.© 2005 Wiley-Liss, Inc.
Supporting Information
This article contains Supplementary Material, available at http://www.interscience.wiley.com/jpages/1059-7754/suppmat
Filename | Description |
---|---|
jwsHUMUv26.1.36.fig1.doc401.5 KB | Supplementary Figure S1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- Ahmad NN, McDonald-McGinn DM, Zackai EH, Knowlton RG, LaRossa D, DiMascio J, Prockop DJ. 1993. A second mutation in the type II procollagen gene (COL2A1) causing Stickler syndrome (arthro-ophthalmopathy) is also a premature termination codon. Am J Hum Genet 52: 39–45.
- Ala-Kokko L, Baldwin CT, Moskowitz RW, Prockop DJ. 1990. Single base mutation in the type II procollagen (COL2A1) as a cause of primary osteoarthritis associated with mild chondrodysplasia. Proc Natl Acad Sci USA 87: 6565–6568.
- Byers PH. 2001. Disorders of collagen biosynthesis and structure. In: CR Scriber, AL Beaudet, WS Sly, D Valle, editors. The metabolic and molecular bases of inherited disease, 8th edition. New York: McGraw-Hill. p 5241–5285.
- Byers PH, Cole WG. 2002. Osteogenesis imperfecta. In: PM Royce, B Steinmann, editors. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, 2nd edition. New York: Wiley-Liss. p 385–430.
10.1002/0471221929.ch8 Google Scholar
- Chan D, Cole WG. 1991. Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells. J Biol Chem 266: 12487–12494.
- Chan D, Taylor TKF, Cole WG. 1993. Characterization of an arginine 789 to cysteine substitution in alpha 1(II) collagen chains of a patient with spondyloepiphyseal dysplasia. J Biol Chem 268: 15238–15245.
- Chan D, Rogers JF, Bateman JF, Cole WG. 1995. Recurrent substitution of arginine 789 by cysteine in pro-alpha 1(II) collagen chains produce spondyloepiphyseal dysplasia congenita. J Rheumatol 22: 37–43.
- Horton WA, Hecht JT. 2002. Chondrodysplasia: disorders of cartilage matrix proteins. In: PM Royce, B Steinmann, editors. Connective tissue and its heritable disorders: molecular, genetic, and medical aspects, 2nd edition. New York: Wiley-Liss. p 909–937.
10.1002/0471221929.ch23(ii) Google Scholar
- Korkko J, Cohn DH, Ala-Kokko L, Krakow D, Prockop DJ. 2000. Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis. Am J Med Genet 92: 95–100.
10.1002/(SICI)1096-8628(20000515)92:2<95::AID-AJMG3>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- Kuivaniemi H, Tromp G, Prockop DJ. 1997. Mutations in fibrillar collagens (types I, II, III, and XI), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 9: 300–315.
10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9 CAS PubMed Web of Science® Google Scholar
- Liberfarb RM, Levy HP, Peter SR, Wilkin DJ, Davis J, Balog JZ, Griffith AJ, Szymko-Bennett YM, Johnston JJ, Francomano CA. 2003. The Stickler syndrome: genotype/phenotype correlation in 10 families with Stickler syndrome resulting from 7 mutations in the type II collagen gene locus COL2A1. Genet Med 5: 21–27.
- Marini JC, Lewis MB, Wang Q, Chen KJ, Orrison BM. 1993. Serine for glycine substitution in type I collagen into two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology. J Biol Chem 268: 2667–2673.
- Mortier GR, Weis M, Nuytinck L, King LM, Wilkin DJ, DePaepe A, Lachman RS, Rimoin DL, Eyre DR, Cohn DH. 2000. Report of five novel and recurrent COL2A1 mutations with analysis of genotype-phenotype correlation in patients with a lethal type II collagen disorder. J Med Genet 37: 263–271.
- Nicholls AC. 1994. Collagen disorder. In: JB Holton, editor. The inherited metabolic diseases, 2nd edition. Edinburgh: Churchill Livingstone. p 379–420.
- Nishimura G, Nakashima E, Mabuchi A, Shimamoto K, Shimamoto T, Shimao Y, Nagai T, Yamaguchi T, Kosaki R, Ohashi H, Makita Y, Ikegawa S. 2004. Identification of COL2A1 mutations in platyspondylic skeletal dysplasia, Torrance type. J Med Genet 41: 75–79.
- Pihlajamaa T, Prockop DJ, Faber J, Winterpacht A, Zabel B, Giedion A, Wiesbauer P, Spranger J, Ala-Kokko L. 1998. Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymuller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome). Am J Med Genet. 80: 115–120.
10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O CAS PubMed Web of Science® Google Scholar
- Richards AJ, Yates JRW, Williams R, Payne SJ, Pope FM, Scott JD, Snead MP. 1996. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha-1(XI) collagen. Hum Mol Genet 5: 1339–1343.
- Richards AJ, Morgan J, Bearcroft PWP, Pickering E, Owen MJ, Holmans P, Williams N, Tysoe C, Pope FM, Snead MP, Hughes H. 2002. Vitreoretinopathy with phalangeal epiphyseal dysplasia, a type II collagenopathy resulting from a novel mutation in the C-propeptide region of the molecule. J Med Genet 39: 661–665.
- Snead MP, Yates JRW. 1999. Clinical and molecular genetics of Stickler syndrome. J Med Genet 36: 353–359.
- Spranger J, Winterpacht A, Zabel B. 1994. The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr 153: 56–65.
- Spranger JW, Brill PW, Poznanski A. 2002. Bone dysplasias: an atlas of genetic disorders of skeletal development, 2nd edition. Oxford: Oxford University Press. p 13–14; p 30–33; p 155–174.
- Tiller GE, Polumbo PA, Weis MA, Bogaert R, Lachman RS, Cohn DH, Rimoin DL, Eyre DR. 1995. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type. Nat Genet 11: 87–89.
- Unger S, Korkko J, Krakow D, Lachman RS, Rimoin DL, Cohn DH. 2001. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita. Am J Med Genet 104: 140–146.
- Vikkula M, Mariman ECM, Lui VCH, Zhidkova NI, Tiller GE, Goldring MB, van Beersum SEC, de Waal Malefijt MC, van den Hoogen FHJ, Ropers H-H, Mayne R, Cheah KSE, Olsen BR, Warman ML, Brunner HG. 1995. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 80: 431–437.
- Wilkin DJ, Bogaert R, Lachman RS, Rimoin DL, Eyre DR, Cohn DH. 1994. A single amino acid substitution (G103D) in the type II collagen triple helix produces Kniest dysplasia. Hum Mol Genet 3: 1999–2003.
- Wilkin DJ, Artz AS, South S, Lachman RS, Rimoin DL, Wilcox WR, McKusick VA, Stratakis CA, Francomano CA, Cohn DH. 1999. Small deletions in the type II collagen triple helix produce Kniest dysplasia. Am J Med Genet 85: 105–112.
10.1002/(SICI)1096-8628(19990716)85:2<105::AID-AJMG2>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Williams CJ, Harrison DA, Hopkinson I, Baldwin CT, Ahmad NN, Ala-Kokko L, Korn RM, Buxton PG, Dimascio J, Considine EL, Prockop DJ. 1992. Detection of sequence variants in the gene for human type II procollagen (COL2A1) by direct sequencing of polymerase chain reaction-amplified genomic DNA. Hum Mutat 1: 403–416.
- Winterpacht A, Hilbert K, Schwartze U, Zabel B. 1995. Non-radioactive multiplex-SSCP analysis: detection of a new type II procollagen gene (COL2A1) mutation. Hum Genet 95: 437–439.
- Wyne-Davies R, Hall C. 1982. Two clinical variants of spondylo-epiphyseal dysplasia. J Bone Joint Surg Br 64: 435–441.
- Wyne-Davies R, Hall CM, Apley AG. 1985. Atlas of skeletal dysplasias. Edinburgh: Churchill Livingstone. p 61–98.
- Zabel B, Hilbert K, Stoss H, Superti-Furga A, Spranger J, Winterpacht A. 1996. A specific collagen type II gene (COL2A1) mutation presenting as spondyloperipheral dysplasia. Am J Med Genet 63: 123–128.
10.1002/(SICI)1096-8628(19960503)63:1<123::AID-AJMG22>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- Zankl A, Zabel B, Hilbert K, Wildhardt G, Cuenot S, Xavier B, Ha-Vinh R, Bonafe L, Spranger J, Superti-Furga A. 2004. Spondyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am J Med Genet 129: 144–148.